{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:39:17Z","timestamp":1792118357050,"version":"4.4.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,3]],"date-time":"2019-08-03T00:00:00Z","timestamp":1564790400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,3]],"date-time":"2019-08-03T00:00:00Z","timestamp":1564790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s10549-019-05384-9","type":"journal-article","created":{"date-parts":[[2019,8,3]],"date-time":"2019-08-03T02:12:13Z","timestamp":1564798333000},"page":"135-140","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Vaginal CO2 laser for the treatment of vulvovaginal atrophy in women with breast cancer: LAAVA pilot study"],"prefix":"10.1007","volume":"178","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6966-5586","authenticated-orcid":false,"given":"Antonia","family":"Pearson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Booker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Tio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,3]]},"reference":[{"issue":"1","key":"5384_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10549-015-3434-z","volume":"152","author":"S Mazzarello","year":"2015","unstructured":"Mazzarello S, Hutton B, Ibrahim MFK, Jacobs C, Shorr R, Smith S, Ng T, Clemons M (2015) Management of urogenital atrophy in breast cancer patients: a systematic review of available evidence from randomized trials. Breast Cancer Res Treat 152(1):1\u20138. \n                    https:\/\/doi.org\/10.1007\/s10549-015-3434-z","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"5384_CR2","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1177\/0193945910391483","volume":"34","author":"J Lester","year":"2012","unstructured":"Lester J, Bernhard L, Ryan-Wenger N (2012) A self-report instrument that describes urogenital atrophy symptoms in breast cancer survivors. West J Nurs Res 34(1):72\u201396. \n                    https:\/\/doi.org\/10.1177\/0193945910391483","journal-title":"West J Nurs Res"},{"issue":"8","key":"5384_CR3","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1200\/jco.1999.17.8.2365","volume":"17","author":"PJ Goodwin","year":"1999","unstructured":"Goodwin PJ, Ennis M, Pritchard KI, Trudeau M, Hood N (1999) Risk of menopause during the 1st year after breast cancer diagnosis. J Clin Oncol 17(8):2365\u20132370. \n                    https:\/\/doi.org\/10.1200\/jco.1999.17.8.2365","journal-title":"J Clin Oncol"},{"issue":"2","key":"5384_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3390\/jpm5020050","volume":"5","author":"J Lester","year":"2015","unstructured":"Lester J, Pahouja G, Andersen B, Lustberg M (2015) Atrophic vaginitis in breast cancer survivors: a difficult survivorship issue. J Pers Med 5(2):50\u201366. \n                    https:\/\/doi.org\/10.3390\/jpm5020050","journal-title":"J Pers Med"},{"issue":"10","key":"5384_CR5","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1097\/gme.0000000000000329","volume":"21","author":"DJ Portman","year":"2014","unstructured":"Portman DJ, Gass ML (2014) Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women\u2019s Sexual Health and the North American Menopause Society. Menopause 21(10):1063\u20131068. \n                    https:\/\/doi.org\/10.1097\/gme.0000000000000329","journal-title":"Menopause"},{"issue":"6","key":"5384_CR6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.clbc.2015.06.005","volume":"15","author":"N Biglia","year":"2015","unstructured":"Biglia N, Bounous VE, Sgro LG, D\u2019Alonzo M, Pecchio S, Nappi RE (2015) Genitourinary syndrome of menopause in breast cancer survivors: are we facing new and safe hopes? Clinical Breast Cancer 15(6):413\u2013420. \n                    https:\/\/doi.org\/10.1016\/j.clbc.2015.06.005","journal-title":"Clinical Breast Cancer"},{"issue":"2","key":"5384_CR7","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3109\/13697137.2014.975197","volume":"18","author":"S Salvatore","year":"2015","unstructured":"Salvatore S, Nappi RE, Parma M, Chionna R, Lagona F, Zerbinati N, Ferrero S, Origoni M, Candiani M, Leone Roberti Maggiore U (2015) Sexual function after fractional microablative CO(2) laser in women with vulvovaginal atrophy. Climacteric 18(2):219\u2013225. \n                    https:\/\/doi.org\/10.3109\/13697137.2014.975197","journal-title":"Climacteric"},{"issue":"21","key":"5384_CR8","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.1200\/jco.2004.08.029","volume":"22","author":"L Fallowfield","year":"2004","unstructured":"Fallowfield L, Cella D, Cuzick J, Francis S, Locker G, Howell A (2004) Quality of life of postmenopausal women in the arimidex, tamoxifen, alone or in combination (ATAC) adjuvant breast cancer trial. J Clin Oncol 22(21):4261\u20134271. \n                    https:\/\/doi.org\/10.1200\/jco.2004.08.029","journal-title":"J Clin Oncol"},{"issue":"1","key":"5384_CR9","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10103-014-1677-2","volume":"30","author":"N Zerbinati","year":"2015","unstructured":"Zerbinati N, Serati M, Origoni M, Candiani M, Iannitti T, Salvatore S, Marotta F, Calligaro A (2015) Microscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment. Lasers Med Sci 30(1):429\u2013436. \n                    https:\/\/doi.org\/10.1007\/s10103-014-1677-2","journal-title":"Lasers Med Sci"},{"issue":"4","key":"5384_CR10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3109\/13697137.2014.899347","volume":"17","author":"S Salvatore","year":"2014","unstructured":"Salvatore S, Nappi RE, Zerbinati N, Calligaro A, Ferrero S, Origoni M, Candiani M, Leone Roberti Maggiore U (2014) A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study. Climacteric 17(4):363\u2013369. \n                    https:\/\/doi.org\/10.3109\/13697137.2014.899347","journal-title":"Climacteric"},{"issue":"1","key":"5384_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/gme.0000000000000955","volume":"25","author":"VL Cruz","year":"2018","unstructured":"Cruz VL, Steiner ML, Pompei LM, Strufaldi R, Fonseca FLA, Santiago LHS, Wajsfeld T, Fernandes CE (2018) Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women. Menopause 25(1):21\u201328. \n                    https:\/\/doi.org\/10.1097\/gme.0000000000000955","journal-title":"Menopause"},{"issue":"6","key":"5384_CR12","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/gme.0000000000001053","volume":"25","author":"T Pagano","year":"2018","unstructured":"Pagano T, De Rosa P, Vallone R, Schettini F, Arpino G, Giuliano M, Lauria R, De Santo I, Conforti A, Gallo A, Nazzaro G, De Placido S, Locci M, De Placido G (2018) Fractional microablative CO2 laser in breast cancer survivors affected by iatrogenic vulvovaginal atrophy after failure of nonestrogenic local treatments: a retrospective study. Menopause 25(6):657\u2013662. \n                    https:\/\/doi.org\/10.1097\/gme.0000000000001053","journal-title":"Menopause"},{"issue":"4","key":"5384_CR13","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00404-016-4118-6","volume":"294","author":"A Pieralli","year":"2016","unstructured":"Pieralli A, Fallani MG, Becorpi A, Bianchi C, Corioni S, Longinotti M, Tredici Z, Guaschino S (2016) Fractional CO2 laser for vulvovaginal atrophy (VVA) dyspareunia relief in breast cancer survivors. Arch Gynecol Obstet 294(4):841\u2013846. \n                    https:\/\/doi.org\/10.1007\/s00404-016-4118-6","journal-title":"Arch Gynecol Obstet"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05384-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-019-05384-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05384-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T19:15:13Z","timestamp":1596309313000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-019-05384-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,3]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["5384"],"URL":"https:\/\/doi.org\/10.1007\/s10549-019-05384-9","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,3]]},"assertion":[{"value":"24 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This study was approved by the Adventist HealthCare Limited Human Research Ethics Committee (HREC). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standard.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}}]}}